A loop-mediated isothermal amplification (LAMP) procedure for the detection of Cryptosporidium in envi ronmental and fecal samples was developed and evaluated. This is the first demonstration of LAMP applied to detection of Cryptosporidium. Due to its specificity and simplicity, the method could become a useful diagnostic tool for epidemiologic studies of Cryptosporidium presence.
Cryptosporidiosis is a disease of major public health concern caused by several genotypically and phenotypically diverse Cryptosporidium species. The role of w ater and food in the epidemiology of this disease is now well recognized (3, 5) . Cryptosporidium hosts excrete large numbers of infective, transmissive stages (oocysts) in feces. A part from the difficul ties of isolation, detection of Cryptosporidium from environ m ental samples by currently available m ethods remains diffi cult and costly, restricting their use by diagnostic laboratories. Loop-m ediated isotherm al amplification (LAMP), developed originally by Notom i et al. (10) , is a novel m ethod th at am pli fies D N A with high specificity, efficiency, and rapidity under isotherm al conditions. It is based on autocycling strand dis placem ent D N A synthesis facilitated by a Bst D N A polymerase (10) . The prim er architecture as applied with appropriate D N A polymerase generates, as described originally by Notomi et al., "stem-loop DNAs with several inverted repeats of the target and cauliflower-like structures with multiple loops" (10) . These are double-stranded D N A fragments in multiples of a given length producing characteristic ladder banding patterns when electrophoresed. The LAMP m ethod can amplify a few copies of D N A to 109 copies in less than an hour under iso therm al conditions. In LAMP, the use of four prim ers that recognize six sequences of the target gene at the initial stage and four during next stages eliminates nonspecific binding, thereby ensuring the specificity of LAMP. The successful de velopm ent of LAMP procedures has been reported for many clinical applications, including viral and bacterial infections, and for diagnoses of protozoan diseases, including trypanoso miasis (8, 11) and both canine and equine piroplasmosis (1, 4) .
The critical element in developing LAMP for a previously untested organism is primer target selection and design, which is facilitated by computer programs available online (http: //primerexplorer.jp). A non-DNA-containing (e.g., distilled wa ter) negative control is typically used to ensure no amplification from the reaction mixture alone. Here, we report on the devel opment and preliminary evaluation of LAMP for detection of Cryptosporidium presence and address its possible usefulness in epidemiologic studies.
The LAMP primer set used here was designed from the 60-kDa glycoprotein (gp60) gene of Cryptosporidium patvum (GenBank accession no. AB237136), which amplifies a 189-bp product, using prim er explorer software (http://prim erexplorer.jp). The LAMP prim er sequences are as follows: F3, 5'-TCG CAC CAG CAA A TA A G G C-3'; B3, 5 
'-G C C G C A T T C TTC T I T T G G A G -3'; FIP, 5'-A CC CTG GCT ACC A G A A G C TTC A G A ACT G G A GAC G CA G A A-3'; BIP, 5 '-GG CCA A ACT A G T GCT GCT TCC CGT TTC G G T A G T TG C GCC TT-3'. The
LAMP reaction was conducted as described previously (10) . Briefly, each reaction mixture (total volume, 25 p i ) contained 12. Tris-acetic acid-EDTA agarose gel and stained with ethidium bromide for visualization under U V light.
Double-distilled w ater (DDW ) samples were also used as a negative control for all sensitivity test reactions. In these tests, cryptosporidial D N A was extracted by freeze-thaw cycling. Briefly, 500 pi genome extraction buffer (0.2 M NaCl, 10 mM Tris-HCl [pH 8.0], 10 mM E D T A [pH 8.0], 1% sodium dodecyl sulfate) was added to oocyst suspensions and then vortexed, followed by 10 freeze-thaw cycles of 2 min in liquid nitrogen and 2 min at 100°C. Afterwards, 10 pi of proteinase K (final concentration, 100 p-g/ml) was added and samples were incu bated at 55°C overnight. The following day, D N A was ex tracted by phenol-chloroform-isoamyl (25:24:1) and precipi tated with 1 ml of 100% ethanol and 50 pi of 1 M sodium acetate. Finally, precipitated D N A was dissolved in 30 p i of DDW . Serial D N A dilutions were prepared as follows: ex tracted D N A was quantified using a spectrophotom eter (Ultrospec 2100) and then serially diluted 1:10 seven times from 4 p.g/p.1 (initial concentration) down to 400 fg/pi (1:107).
The genomic D N A used to test the LAMP prim er set spec ificity was from C. parvum of a bovine origin that has been identified as C. parvum genotype II (referred to hereinafter as C. parvum) (data not shown). For negative controls, distilled w ater and the D N A of various parasites, including Trypano soma brucei (G U T at 1.3), Babesia bovis (USD A strain), Theileria paiva (Muguga strain), and Toxoplasma gondii (RH strain), as well as uninfected bovine blood D N A were used. Enteric pathogens more common in fecal or w ater samples but more distantly related to the target organism and thus unlikely to generate false positives are being included in continuing work. The LAMP outer primers (F3 and B3) were used for PCR with a product size of 189 bp for comparison of the two methods. Clearly, both LAMP and PCR specifically amplified Cryptosporidium D N A whereas negative-control D N A was not amplified (Fig. 1) .
The sensitivity o f this LAMP application was assessed in two ways. For the first sensitivity test, D N A was extracted from ca. 106 C. parvum oocysts purified from a bovine fecal sample. The D N A was quantified by a spectrophotom eter and then serially diluted sevenfold to a minimum D N A concentration equiva lent to that of 0.1 oocysts. The LAMP procedure amplified the serially diluted C. parvum D N A for each dilution from the highest sample D N A concentration of 4 p.g/p.1 to as little as 400 fg/pd (dilution of 1:107) ( Fig. 2, upper) . In comparison, PCR amplified the diluted D N A only to a 1:103 dilution (Fig. 2,  lower) . For the second sensitivity test, 1 X 106 oocysts from the stock isolate were diluted 1:10 serially sevenfold to a minimum concentration equivalent to that of a single oocyst. Then, D NA was extracted from each oocyst dilution. The LAM P procedure amplified the D N A of C. parvum oocysts diluted to a minimum concentration equivalent to that of a single oocyst (Fig. 3,  upper) . In comparison, PCR amplified the same D N A only to a minimum concentration equivalent to that of 1 X 105 oocysts (Fig. 3, lower) .
Environm ental fecal and w ater samples previously (6) proven positive by an immunofluorescence test (Cellabs Pty. Ltd., A ustralia) or by PCR (data not shown) used in this application were from a variety of both geographic and host origins (1 cattle and 1 snake, Germany; 1 human and 1 cattle, Japan; 1 leopard, China; 11 cattle, Mongolia; 1 cattle, Spain; 1 cattle, Hungary; 7 river w ater samples, Bulgaria). LAMP de tected Cryptosporidium D N A in all of the above-mentioned samples. The seven river w ater samples have previously been reported to be positive for Cryptosporidium presence by an immunofluorescence test (6) . LAMP amplified Cryptospo ridium D N A from all of the w ater samples tested, while PCR did not detect D N A in any of them (unpublished data). The 
